Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E D Chamuleau

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunobiology|August 22, 2006
MHC class II molecules in tumour immunology: prognostic marker and target for immune modulationM E D Chamuleau, G J Ossenkoppele, A A van de Loosdrecht
Haematologica|May 20, 2006
Mixed autoimmune haemolysis in a SLE patient due to aspecific and anti-Jka autoantibodies; case report and review of the literatureM J Wondergem, M Overbeeke, N Som, et al.
Haematologica|April 12, 2003
Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patientM E D Chamuleau, W Deenik, S Zweegman, et al.
Blood|January 29, 2021
Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018D E Issa, R L Seefat, O Visser, et al.
Blood Cancer Journal|January 4, 2024
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphomaA V de Jonge, J A A Bult, D F E Karssing, et al.
The Netherlands Journal of Medicine|November 8, 2011
Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011A P Kater, S Wittebol, M E D Chamuleau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2017
Emergence of carbapenemase-producing Acinetobacter ursingii in The NetherlandsE Sieswerda, R P Schade, T Bosch, et al.
Journal of Cardiovascular Translational Research|May 17, 2014
Cyclosporin in cell therapy for cardiac regenerationS J Jansen Of Lorkeers, E Hart, X L Tang, et al.
Leukemia Research|February 2, 2011
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2M E D Chamuleau, G J Ossenkoppele, A van Rhenen, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunobiology|August 22, 2006
MHC class II molecules in tumour immunology: prognostic marker and target for immune modulationM E D Chamuleau, G J Ossenkoppele, A A van de Loosdrecht
Haematologica|May 20, 2006
Mixed autoimmune haemolysis in a SLE patient due to aspecific and anti-Jka autoantibodies; case report and review of the literatureM J Wondergem, M Overbeeke, N Som, et al.
Haematologica|April 12, 2003
Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patientM E D Chamuleau, W Deenik, S Zweegman, et al.
Blood|January 29, 2021
Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018D E Issa, R L Seefat, O Visser, et al.
Blood Cancer Journal|January 4, 2024
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphomaA V de Jonge, J A A Bult, D F E Karssing, et al.
The Netherlands Journal of Medicine|November 8, 2011
Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011A P Kater, S Wittebol, M E D Chamuleau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2017
Emergence of carbapenemase-producing Acinetobacter ursingii in The NetherlandsE Sieswerda, R P Schade, T Bosch, et al.
Journal of Cardiovascular Translational Research|May 17, 2014
Cyclosporin in cell therapy for cardiac regenerationS J Jansen Of Lorkeers, E Hart, X L Tang, et al.
Leukemia Research|February 2, 2011
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2M E D Chamuleau, G J Ossenkoppele, A van Rhenen, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Pageof 2